News

GEN - Genetic Engineering and Biotechnology News33m
Blocking Erythropoietin Signaling in Mice Converts Liver Tumors into Immunotherapy Responders
Removing EPO signalling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
GEN - Genetic Engineering and Biotechnology News33m
Blocking Erythropoietin Signaling Renders Mouse Liver Tumors Sensitive to Anti-PD-1 Therapy
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
GEN - Genetic Engineering and Biotechnology News44m
New Podcast, The ImmunoVerse, Highlights Immunotherapy Research
Moffitt Cancer Center launches new podcast, The ImmunoVerse, where Patrick Hwu, MD, will discuss immunotherapy research with ...